Exploring the Association of Small Dense Low-Density Lipoprotein Cholesterol and Ischemia-Modified Albumin in Hyperlipidemic Patients
Frontiers in Medical and Clinical Sciences · 2025
DOI: 10.64917/fmcs-003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medical and Clinical Sciences, 2025. Verfasst von Dr. Juan Carlos Mendoza und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Small dense low-density lipoprotein cholesterol (sdLDL-C) is recognized as a highly atherogenic lipoprotein subfraction implicated in cardiovascular risk. Ischemia-modified albumin (IMA) serves as a biomarker of oxidative stress and ischemic conditions. Both markers are important in understanding the pathophysiology of hyperlipidemia-related cardiovascular diseases.
Objective
This study investigates the relationship between sdLDL-C levels and IMA concentrations in patients with hyperlipidemia to elucidate potential synergistic roles in cardiovascular risk stratification.
Methods
A cross-sectional analysis was conducted on hyperlipidemic patients attending a tertiary care center. Serum sdLDL-C and IMA levels were measured and correlated with lipid profiles and clinical parameters. Statistical analyses evaluated the strength and significance of associations.
Results
Elevated sdLDL-C levels showed a significant positive correlation with increased IMA concentrations, indicating heightened oxidative stress in hyperlipidemic patients. This association suggests that combined measurement of sdLDL-C and IMA could improve early detection of vascular ischemia and risk assessment.
Conclusion
The findings support a close link between atherogenic lipoprotein subfractions and ischemia-related oxidative modifications in hyperlipidemia. Integrating sdLDL-C and IMA assessments may enhance cardiovascular risk prediction and guide therapeutic interventions.
Zitieren
APA
Mendoza, D. J. C., & Ramírez, D. L. S. (2025). Exploring the Association of Small Dense Low-Density Lipoprotein Cholesterol and Ischemia-Modified Albumin in Hyperlipidemic Patients. Frontiers in Medical and Clinical Sciences. https://doi.org/10.64917/fmcs-003
Vancouver
Mendoza DJC, Ramírez DLS. Exploring the Association of Small Dense Low-Density Lipoprotein Cholesterol and Ischemia-Modified Albumin in Hyperlipidemic Patients. Frontiers in Medical and Clinical Sciences. 2025. doi:10.64917/fmcs-003
BibTeX
@article{Mendoza2025,
author = {Mendoza, Dr. Juan Carlos and Ramírez, Dr. Laura Sofía},
title = {Exploring the Association of Small Dense Low-Density Lipoprotein Cholesterol and Ischemia-Modified Albumin in Hyperlipidemic Patients},
journal = {Frontiers in Medical and Clinical Sciences},
year = {2025},
doi = {10.64917/fmcs-003}
}
EUVIMED